SME INSTRUMENT PHASE 1 – DIALYBRID – December 1, 2018

SME INSTRUMENT PHASE 1 – DIALYBRID – December 1, 2018

Bioengineering Laboratories was awarded the illustrious (and highly competitive!) SME Instrument Phase 1 grant, appointed by the European Commission to SMEs with a strong growth potential and the ambition to become world-market leaders. The grant will support BEL in undertaking the DIALYBRID project, aimed at revolutionizing the world of hemodialysis with a novel, hybrid vascular access made of Silkothane®.

1st ITALIAN VAS CHAPTER – November 17, 2018

1st ITALIAN VAS CHAPTER – November 17, 2018

Bioengineering Laboratories gladly accepts the invitation to join the 1st Italian Chapter of the Vascular Access Society, held in Turin together with the 7th national congress of the “Vascular Access Design Group”. Many thanks to the organizers, Dr. Giacomo Forneris and Dr. Daniele Savio, for giving BEL the possibility to illustrate the breakthrough potential of Silkothane® in the world of hemodialysis.

BUSINESS PLAN COMPETITION – September 5, 2018

BUSINESS PLAN COMPETITION – September 5, 2018

Bioengineering Laboratories was awarded the second prize at the Business Plan Competition of the 5th World Congress of TERMIS – Tissue Engineering and Regenerative Medicine International Society (Kyoto, Japan, https://www.termis.org/wc2018). BEL’s business plan and presentation pitch focused on the DIALYBRID project, aimed at revolutionizing the world of hemodialysis with a novel, hybrid vascular access made of Silkothane®.

BEL @ EMBC 2018 Honolulu

BEL @ EMBC 2018 Honolulu

Bioengineering Laboratories joined the “40th International Conference of the IEEE Engineering in Medicine and Biology Society” (Honolulu, Hawaii), to present, in collaboration with Politecnico di Milano, the results obtained by the biological tissues analysis through modulus and phase of impedance. The developed device is composed by a needle-prove and an ad-hoc impedance meter for the analysis and discrimination of living tissues.

Seal of excellence

Seal of excellence

Bioengineering Laboratories was awarded the prestigious “Seal of excellence” of the European Commission for its project DIALYBRID, aimed at revolutionizing the world of hemodialysis with a novel, hybrid vascular access made of Silkothane®.

The project was submitted under the Horizon 2020’s “SME Instrument – Phase 1” call of May 3rd, 2018, and it was scored as a high-quality project proposal in a highly competitive evaluation process.

Download the certificate